Your session is about to expire
← Back to Search
Nerve Block for Cleft Palate Pain Control
Study Summary
This trial found that nerve blocks may provide more effective pain control for cleft palate repair than opioids, leading to shorter hospital stays.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I need surgery for my palate that may include other procedures to help with my speech.I need a second surgery on my palate.I have a long-term pain condition.I am having surgery to repair a cleft palate only.I do not have a chronic pain condition.
- Group 1: 25 Gauge needle
- Group 2: Suprazygomatic maxillary nerve blockade
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
In what scenarios is Ropivacaine typically deployed as a medical treatment?
"When it comes to anesthesia, ropivacaine is a common go-to. This medication can also be utilized for labor pain and postoperative discomfort in addition to its traditional usage of surgical anaesthesia."
Who is eligible to partake in this clinical trial?
"This experiment is open to 40 infants between 3 months and 5 years afflicted with orofacial deformities. The primary requirements for enrolment are: the presenting condition should be a cleft palate, parental/guardian consent must be obtained, participants need to have been able to consume food/water before surgery, no pre-existing chronic pain disorder."
Are there any preceding studies involving Ropivacaine that are worth taking into consideration?
"At present, there are 67 live clinical trials examining the efficacy of Ropivacaine. Of those ongoing studies, 15 have reached Phase 3 and span 89 locations - primarily in Karachi, Sindh."
Are senior citizens eligible for this experiment?
"The guidelines for this medical trial state that participants must be between 3 Months and 5 years of age."
Are there any openings available within this clinical trial?
"This clinical trial is no longer enrolling participants, as the last update on its data was made on May 23rd 2022. For those interested in other studies, there are currently 126 investigations for mouth abnormalities and 67 trials involving Ropivacaine that need volunteers to take part."
How many individuals are being recruited as participants in this clinical trial?
"Unfortunately, this clinical trial is no longer seeking candidates. It was initially posted on November 20th 2018 and its last edit occurred on May 23rd 2022. For those looking for other options, 126 studies are actively searching for participants with oral irregularities and 67 trials utilising Ropivacaine have begun accepting patients."
Share this study with friends
Copy Link
Messenger